Chronic pain, cannabis legalisation, and cannabis use disorder among patients in the US Veterans Health Administration system, 2005 to 2019: a repeated, cross-sectional study

The Lancet Psychiatry, Journal Year: 2023, Volume and Issue: 10(11), P. 877 - 886

Published: Oct. 11, 2023

Language: Английский

---

Unlocking the Potential: The Synergy Between Gender Diversity and Corporate Social Responsibility Reporting in India

Approaches to global sustainability, markets, and governance, Journal Year: 2025, Volume and Issue: unknown, P. 271 - 286

Published: Jan. 1, 2025

Language: Английский

---

The opioid industry's use of scientific evidence to advance claims about prescription opioid safety and effectiveness

Health Affairs Scholar, Journal Year: 2024, Volume and Issue: 2(10)

Published: Oct. 1, 2024

It is widely recognized that pharmaceutical marketing contributed to the ongoing US opioid epidemic, but less understood about how industry used scientific evidence generate product demand, shape regulation, and change clinician behavior. In this qualitative study, we characterize select articles by support safety effectiveness claims use a novel database, Opioid Industry Documents Archive, determine notable elements of non-industry documents citing advance each claim. We found 15 were collectively mentioned in 3666 supporting 5 common, inaccurate claims: opioids are effective for treatment chronic, non-cancer pain; "rarely" addictive; "pseudo-addiction" due inadequate pain management; no dose too high; screening tools can identify those at risk developing addiction. The eventual normalization these symbolically associating with evidence, building credibility, expanding diversifying audiences parties asserting claims, obfuscating conflicts interest. These findings have implications regulators products corporate activity inform efforts prevent similar public health crises.

Language: Английский

---

Medicinal Cannabis Use for Rheumatic Conditions in the US Versus Canada: Rationale for Use and Patient–Health Care Provider Interactions

ACR Open Rheumatology, Journal Year: 2023, Volume and Issue: 5(9), P. 443 - 453

Published: July 31, 2023

Understanding how medical cannabis (MC) use is integrated into practice for rheumatic disease management essential. We characterized rationale MC use, patient-physician interactions around MC, and patterns among people with conditions in the US Canada.We surveyed 3406 participants Canada, 1727 completing survey (50.7% response rate). assessed disclosure of to health care providers, authorization by investigated factors associated providers versus Canada.Overall, 54.9% respondents 78.0% Canadians reported past or current typically because inadequate symptom relief from other medications. Compared those fewer obtained licenses, disclosed their asked advice on (all P values <0.001). Overall, 47.4% Canadian 28.2% rated professionals as most trusted information source. legality state residence was 2.49 greater odds disclosing (95% confidence interval: 1.49-4.16, < 0.001) US, whereas there were no Canada. Our study limited our convenience sampling strategy cross-sectional design.Despite widespread availability, poorly care, patients self-directing minimal clinical oversight. Concerted efforts integrate education policy critical.

Language: Английский

---

Corporate activities that influence population health: A scoping review and qualitative synthesis to develop the HEALTH-CORP typology

medRxiv (Cold Spring Harbor Laboratory), Journal Year: 2024, Volume and Issue: unknown

Published: April 10, 2024

Introduction The concept of the commercial determinants health (CDH) is used to study actions (and associated structures) entities that influence population and equity. aim this was develop a typology describes diverse set activities through which corporations equity across industries. Methods We conducted scoping review articles using CDH terms (n=116) discuss corporate can 16 qualitative constant comparison method build called Corporate Influences on Population Health (HEALTH-CORP) typology. Results HEALTH-CORP identifies 70 industries categorizes them into seven domains (e.g., political practices, employment practices). present model situates these based their proximity outcomes identify five groups workers, local communities) consider when evaluating impacts. Discussion facilitates an understanding affected by activities. utility contributions in identifying interventions address advancing efforts measure monitor CDH. also leverage our findings key gaps literature suggest avenues for future research.

Language: Английский

---

Bridging the Divide: Exploring Nonprofits’ Perceptions of Cannabis Philanthropy in the Changing Legal Landscape of the United States

Journal of Drug Issues, Journal Year: 2024, Volume and Issue: unknown

Published: May 7, 2024

Cannabis dispensaries in the U.S. aim to contribute communities through philanthropy, but some nonprofits hesitate accept donations. This exploratory case study Colorado investigates nonprofits’ perceptions of cannabis philanthropy by surveying 317 organizations. Despite being illegal federally legal at state level, most respondents viewed positively. Of who had negative views, many believe their views would shift if were legalized. Furthermore, majority do not consider funds derived from sales as “tainted” or coming a morally questionable source. The findings shed light on complexity how is perceived, informing can adapt proactively evolving dynamics, particularly considering potential shifts federal law. Additionally, reveals favorable environment for industry engage and partnerships with nonprofits, positive impacts such activities.

Language: Английский

---

Corporate activities that influence population health: a scoping review and qualitative synthesis to develop the HEALTH-CORP typology

Globalization and Health, Journal Year: 2024, Volume and Issue: 20(1)

Published: Nov. 9, 2024

The concept of the commercial determinants health (CDH) is used to study actions entities and political economic systems, structures, norms that enable these ultimately influence population inequity. aim this was develop a typology describes diverse set activities through which equity across industries.

Language: Английский

---

Cannabis industry campaign expenditures in Colorado, 2005-2021

International Journal of Drug Policy, Journal Year: 2023, Volume and Issue: 119, P. 104156 - 104156

Published: Aug. 7, 2023

The cannabis industry has been described using the commercial determinants of health framework because it seeks to increase sales and profits through efforts change political environment. To understanding these industry's efforts, this study describes campaign contributions in Colorado an analysis public records.We reviewed datasets posted online at Secretary State's Transparent Contribution Expenditure Reporting (TRACER) Campaign Finance System. We generated descriptive data on elections conducted regressions identify predictors contributions, associations between lagged a legislator's score (how closely aligned lawmaker's legislative history is with from -1 1).Between 2005-2021, 429 cannabis-affiliated contributors gave $4,658,385 (2021 inflation-adjusted) 512 electoral committees. Contributions came primarily non-profits (45%), businesses (27%), individuals (25%). After recreational legalization 2012, non-profit donors ties way businesses, business owners, lobbyists. Cannabis local state-wide ballot initiative campaigns historically made up majority spending, but candidate committees more than tripled 2009-2010 cycle 2019-2020 cycle. From 2017-2020, every $10,000 donations affiliated was associated 0.245-point (p=0.04).Cannabis-affiliated interests substantial Colorado. Public advocates should monitor connections lawmakers tactics used mask source contributions. Continued surveillance essential exposing conflicts interest preventing undue influence.

Language: Английский

---

Government Investment in the Marijuana Industry’s Commercial Interests Harms Vulnerable Groups

American Journal of Public Health, Journal Year: 2023, Volume and Issue: 113(5), P. 484 - 486

Published: March 16, 2023

Government Investment in the Marijuana Industry’s Commercial Interests Harms Vulnerable Groups Linda Richter PhD, Robyn Oster BA, and Lindsey Vuolo JD, MPH Affiliation All authors are with Partnership to End Addiction, New York, NY. CopyRightCorrespondence should be sent Richter, 711 Third Ave, 5th Floor, Suite 500, NY 10017 (e-mail: [email protected]org). Reprints can ordered at http://www.ajph.org by clicking “Reprints” link. CONTRIBUTORS contributed conceptualizing, drafting, revising this editorial approved final version. https://doi.org/10.2105/AJPH.2023.307257 Accepted: February 04, 2023 Published Online: March 16,

Language: Английский

---

Chronic Pain, Cannabis Legalization and Cannabis Use Disorder in Veterans Health Administration Patients, 2005 to 2019

medRxiv (Cold Spring Harbor Laboratory), Journal Year: 2023, Volume and Issue: unknown

Published: July 12, 2023

The risk for cannabis use disorder (CUD) is elevated among U.S. adults with chronic pain, and CUD rates are disproportionately increasing in this group. Little known about the role of medical laws (MCL) recreational (RCL) these increases. Among Veterans Health Administration (VHA) patients, we examined whether MCL RCL effects on prevalence differed between patients without pain.Patients ≥1 primary care, emergency, or mental health visit to VHA no hospice/palliative care within a given calendar year, 2005-2019 (yearly n=3,234,382 4,579,994) were analyzed using electronic record (EHR) data. To estimate enactment increases diagnosed staggered-adoption difference-in-difference analyses used, fitting linear binomial regression model fixed state, categorical time-varying law status, state-level sociodemographic covariates, pain indicator, patient covariates (age group [18-34, 35-64; 65-75], sex, race ethnicity). Pain was categorized an American Society taxonomy painful conditions.In enacting led 0·14% (95% CI=0·12%-0·15%) absolute increase prevalence, 8·4% total MCL-enacting states attributable MCL. Enacting 0·19% (95%CI: 0·16%, 0·22%) 11·5% RCL-enacting RCL. In smaller (MCL: 0·037% [95%CI: 0·03, 0·05]; RCL: 0·042% 0·02, 0·06]), 5·7% 6·0% Overall, significantly greater than pain. By age, negligible age 18-34 35-64 significant (p<0.001) but small. 65-75 0·10% MCL-only 0·22% MCL/RCL states, 9·3% MCL, 19.4% 65-75, pain.In 35-75, those particularly pronounced 65-75. Although offers extensive behavioral non-opioid pharmaceutical treatments may seem more appealing option media enthusiasm cannabis, commercialization activities, widespread public beliefs efficacy. Cannabis does not have risk/mortality profile opioids, clinical condition considerable impairment comorbidity. Because legalization likely further increase, following state concern. as individuals average general population increasing. Therefore, monitoring discussion warranted, especially older patients.Evidence before study: Only three studies and/or adults, finding modest effect sizes. Effects vary across important subgroups population, including PubMed searched by DH publications time trends legalization, disorders from database inception until March 15, 2023, language restrictions. search terms used: (medical laws) AND (pain) (cannabis disorder); (recreational disorder). one study found that had outcome, used cross-sectional data single which cannot be determine over time. evidence has been lacking US adult status.Added value our knowledge, first examine nationally differ experience not. Using included information conditions associated showed stronger ages 65-75.Implications all available evidence: influence through availability portrays 'normal' safe, thereby decreasing perception risk. overall decline prescribed opioids also contributed effects, leading substitution expanded pool vulnerable CUD. programs. However, positive reports online "information" can sometimes misleading, popular useful prevention treatment agent make preferable evidence-based offers, easily accessible connected healthcare system, who face barriers accessing management. When developing legislation, unintended consequences should considered, increased large population.

Language: Английский

---